Literature DB >> 10690397

Socio-economic deprivation and stage of disease at presentation in women with breast cancer.

U Macleod1, S Ross, C Gillis, A McConnachie, C Twelves, G C Watt.   

Abstract

BACKGROUND: This study describes and compares the pathological prognostic factors and surgeon assessment of stage of breast cancer of women living in affluent and deprived areas to assess whether clinical stage at presentation may explain the known poorer survival outcomes for deprived women. PATIENTS AND METHODS: A population-based review of the case records of 417 women with breast cancer was carried out.
RESULTS: No difference in pathological criteria was found between the 88% of women living in affluent and deprived areas for whom such data were available. Clinical assessment of the remaining 50 cases showed that women living in deprived areas were more likely to present with locally advanced or metastatic disease.
CONCLUSION: The poorer survival of women from deprived areas with breast cancer may be explained by more deprived women presenting with advanced cancers.

Entities:  

Mesh:

Year:  2000        PMID: 10690397     DOI: 10.1023/a:1008385321476

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  22 in total

1.  Relation between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, and lung cancer: results from four national, population based studies.

Authors:  D H Brewster; C S Thomson; D J Hole; R J Black; P L Stroner; C R Gillis
Journal:  BMJ       Date:  2001-04-07

2.  Management of women with early breast cancer. Affluence seems to affect management of breast cancer.

Authors:  J Bell; D Robinson; H Møller
Journal:  BMJ       Date:  2000-12-02

3.  Are there socioeconomic gradients in stage and grade of breast cancer at diagnosis? Cross sectional analysis of UK cancer registry data.

Authors:  Jean Adams; Martin White; David Forman
Journal:  BMJ       Date:  2004-06-02

4.  Primary and secondary care management of women with early breast cancer from affluent and deprived areas: retrospective review of hospital and general practice records.

Authors:  U Macleod; S Ross; C Twelves; W D George; C Gillis; G C Watt
Journal:  BMJ       Date:  2000-05-27

5.  Is the rate of biological aging, as measured by age at diagnosis of cancer, socioeconomically patterned?

Authors:  Jean Adams; Martin White; David Forman
Journal:  J Epidemiol Community Health       Date:  2005-02       Impact factor: 3.710

6.  Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival.

Authors:  C S Thomson; D J Hole; C J Twelves; D H Brewster; R J Black
Journal:  J Epidemiol Community Health       Date:  2001-05       Impact factor: 3.710

7.  Socio-economic disparities in long-term cancer survival-10 year follow-up with individual patient data.

Authors:  Susanne Singer; Michael Bartels; Susanne Briest; Jens Einenkel; Dietger Niederwieser; Kirsten Papsdorf; Jens-Uwe Stolzenburg; Sophie Künstler; Sabine Taubenheim; Oliver Krauß
Journal:  Support Care Cancer       Date:  2016-12-10       Impact factor: 3.603

8.  Socio-economic status and survival from breast cancer for young, Australian, urban women.

Authors:  Katherine I Morley; Roger L Milne; Graham G Giles; Melissa C Southey; Carmel Apicella; John L Hopper; Kelly-Anne Phillips
Journal:  Aust N Z J Public Health       Date:  2010-04       Impact factor: 2.939

9.  Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer.

Authors:  G Lyratzopoulos; G A Abel; C H Brown; B A Rous; S A Vernon; M Roland; D C Greenberg
Journal:  Ann Oncol       Date:  2012-11-12       Impact factor: 32.976

10.  Predictors of early death in female patients with breast cancer in the UK: a cohort study.

Authors:  Ceilidh Stapelkamp; Lars Holmberg; Daniela Tataru; Henrik Møller; David Robinson
Journal:  BMJ Open       Date:  2011-11-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.